Aclaris Therapeutics Inc. (ACRS)
NASDAQ: ACRS
· Real-Time Price · USD
1.88
0.19 (11.24%)
At close: Aug 15, 2025, 3:59 PM
1.83
-2.40%
After-hours: Aug 15, 2025, 07:57 PM EDT
Aclaris Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 16.79M | 17.78M | 18.72M | 27.08M | 32.02M | 31.12M | 31.25M | 21.43M | 31.17M | 30.83M | 29.75M | 23.5M | 6.14M | 6.44M | 6.76M | 6.84M | 6.63M | 6.85M |
Cost of Revenue | 12.73M | 14.12M | 15.46M | 12.59M | 11.03M | 10.71M | 10.74M | 5.82M | 13.2M | 12.67M | 11.96M | 11.6M | 4.47M | 4.67M | 4.71M | 4.85M | 4.94M | 5.07M |
Gross Profit | 4.06M | 3.65M | 3.26M | 14.49M | 20.99M | 20.41M | 20.51M | 15.61M | 17.97M | 18.15M | 17.79M | 11.9M | 1.67M | 1.77M | 2.05M | 1.99M | 1.69M | 1.79M |
Operating Income | -146.64M | -141.08M | -136.63M | -41M | -62.11M | -81.07M | -98.16M | -116.09M | -103.19M | -95.77M | -85.15M | -86.07M | -87.69M | -81.3M | -89.72M | -80.39M | -70.56M | -63.94M |
Interest Income | 8.28M | 8.13M | 7.95M | 5.85M | 6.17M | 4.31M | 2.32M | 2.32M | 922K | 922K | 922K | 922K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -134.65M | -130.21M | -132.06M | -37.37M | -59.05M | -77.63M | -88.85M | -114.63M | -105.32M | -96.28M | -86.91M | -82.08M | -83.27M | -80.9M | -90.86M | -81.84M | -71.35M | -64.76M |
Net Income | -134.65M | -130.21M | -132.06M | -37M | -58.68M | -77.26M | -86.72M | -118.52M | -110.49M | -97.59M | -88.66M | -78.17M | -78.09M | -79.58M | -90.86M | -81.23M | -70.75M | -64.18M |
Selling & General & Admin | 22.13M | 21.4M | 19.6M | 22.86M | 24.3M | 27.97M | 32.41M | 31.34M | 30.07M | 27.82M | 25.13M | 24.93M | 25.1M | 24.89M | 23.62M | 21.57M | 19.45M | 19.16M |
Research & Development | 38.02M | 35.33M | 33.59M | 51.21M | 69.13M | 85.64M | 98.38M | 92.81M | 92.59M | 86.09M | 77.81M | 70.84M | 61.16M | 50.28M | 43.81M | 38.67M | 31.56M | 30.13M |
Other Expenses | 90.55M | 88.02M | 86.7M | -18.57M | -10.33M | -10.63M | -10.63M | 9.04M | n/a | n/a | 118K | 207K | 207K | 207K | 89K | n/a | n/a | n/a |
Operating Expenses | 150.7M | 144.74M | 139.89M | 55.5M | 83.1M | 102.98M | 120.17M | 133.2M | 122.66M | 113.92M | 102.95M | 95.77M | 86.26M | 75.17M | 67.43M | 60.24M | 51.01M | 49.28M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.91M | 9.11M | 9.11M | 9.11M | 2.2M | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | -100K | -2.6M | -2.6M | -2.6M | -2.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 163.43M | 158.86M | 160.65M | 73.38M | 99.42M | 118.99M | 130.91M | 139.02M | 135.85M | 126.59M | 114.91M | 107.37M | 90.73M | 79.84M | 72.14M | 65.09M | 55.95M | 54.35M |
Income Tax Expense | n/a | n/a | n/a | -367K | -367K | -367K | -2.13M | 3.9M | 5.18M | 1.31M | 1.75M | -3.9M | -5.18M | -1.32M | n/a | -182K | -182K | -155K |
Shares Outstanding (Basic) | 122.58M | 122.39M | 95.31M | 71.38M | 71.29M | 71.07M | 70.87M | 70.81M | 70.63M | 66.87M | 66.69M | 66.68M | 65.99M | 61.43M | 61.23M | 61.22M | 53.97M | 50.34M |
Shares Outstanding (Diluted) | 122.58M | 122.39M | 95.31M | 71.38M | 71.29M | 71.07M | 70.87M | 70.81M | 70.63M | 66.87M | 66.69M | 66.68M | 65.99M | 61.43M | 61.23M | 61.22M | 53.97M | 50.34M |
EPS (Basic) | -1.37 | -1.39 | -1.51 | -0.52 | -0.82 | -1.09 | -1.24 | -1.72 | -1.63 | -1.46 | -1.35 | -1.22 | -1.25 | -1.34 | -1.63 | -1.56 | -1.46 | -1.4 |
EPS (Diluted) | -1.37 | -1.39 | -1.51 | -0.52 | -0.82 | -1.09 | -1.24 | -1.72 | -1.63 | -1.46 | -1.35 | -1.22 | -1.25 | -1.34 | -1.63 | -1.56 | -1.46 | -1.4 |
EBITDA | -56.29M | -53.69M | -51.92M | -61.58M | -81.13M | -100.33M | -114.36M | -118.22M | -107.85M | -100.42M | -89.41M | -82.58M | -83.25M | -72.03M | -65.13M | -58.08M | -48.28M | -45.89M |
EBIT | -56.95M | -54.18M | -52.53M | -62.17M | -80.28M | -99.92M | -114.51M | -112.77M | -103.67M | -95.77M | -85.15M | -83.87M | -84.59M | -73.4M | -65.38M | -58.25M | -49.32M | -47.5M |
Depreciation & Amortization | 664K | 492K | 607K | 692K | 732K | 908K | 863K | 825K | 799K | 787K | 797K | 804K | 802K | 843K | 923K | 277K | 677K | 1.04M |